Sections
Shows
Events
India may see fourth COVID wave around 22 June: IIT Kanpur study
Covaxin produces 'robust' antibody response with no serious adverse events, Phase 1 trials show
Indian scientists recommend testing asymptomatic COVID-19 patients, say viral load higher in them
